Pure aortic valve regurgitation: SAVR is the gold standard, but TAVR is another gun
- 11 March 2020
- journal article
- editorial
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 95 (4) , 817-818
Abstract
Key Points: Surgical treatment is the gold standard for pure aortic regurgitation (AR). In this study, transcatheter aortic valve replacement (TAVR) appears to be a promising option for inoperable/high‐risk patients suffering pure AR. Long‐term results and specific patient‐level data are needed to better clarify the role of TAVR in pure AR treatment.Keywords
This publication has 4 references indexed in Scilit:
- Transcatheter aortic valve replacement for bicuspid aortic valve stenosis with first- and new-generation bioprostheses: A systematic review and meta-analysisInternational Journal of Cardiology, 2020
- Nationwide outcomes of aortic valve replacement for pure aortic regurgitation in Germany 2008–2015Catheterization and Cardiovascular Interventions, 2019
- Transcatheter Aortic Valve Replacement in Pure Native Aortic Valve RegurgitationJACC, 2017
- A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart DiseaseEuropean Heart Journal, 2003